(Q52216671)

27 April 2018

title

Pharmacokinetics of ibuprofen in patients with cystic fibrosis. (English)

1 reference

27 April 2018

0 references

1 reference

Murry DJ

1

1 reference

27 April 2018

Oermann CM

2

1 reference

27 April 2018

Ou CN

3

1 reference

27 April 2018

Rognerud C

4

1 reference

27 April 2018

Seilheimer DK

5

1 reference

27 April 2018

Sockrider MM

6

1 reference

27 April 2018

language of work or name

English

0 references

publication date

1 March 1999

1 reference

27 April 2018

published in

Pharmacotherapy

1 reference

27 April 2018

volume

19

1 reference

27 April 2018

issue

3

1 reference

27 April 2018

page(s)

340-345

1 reference

27 April 2018

Effect of high-dose ibuprofen in patients with cystic fibrosis.

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.340.30944

Clinical pharmacology of antibiotics and other drugs in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.340.30944

Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.340.30944

Lean body mass as a predictor of drug dosage. Implications for drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.340.30944

Response of premature infants with severe respiratory failure to inhaled nitric oxide. Preemie NO Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.340.30944

A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.340.30944

Altered prednisolone pharmacokinetics in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.340.30944

Ibuprofen in children with cystic fibrosis: pharmacokinetics and adverse effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.340.30944

10.1592/PHCO.19.4.340.30944

21 January 2018

Identifiers

DOI

1 reference

27 April 2018

1 reference

27 April 2018